Page 166 - எங்களுக்கு தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca Moves From Favored Child To Problem Child Among Vaccines AstraZeneca Moves From Favored Child To Problem Child Among Vaccines But at around 5 the next morning, Pangalos was jolted out of bed in the U.K. by a call from AstraZeneca Chief Executive Officer Pascal Soriot, ringing from Australia to ask what on earth was happening. Updated: April 08, 2021 2:01 pm IST In span of a year, Astra has gone from favored child to problem child in family of coronavirus vaccines. Mene Pangalos, head of biopharmaceuticals research for AstraZeneca Plc, went to bed on Monday, March 22, feeling good for the first time in a while. After working around the clock through the weekend, he d just announced better-than-expected interim results from the company s large U.S. vaccine trial: The shot was safe and 79% effective at preventing cases of symptomatic Covid-19. Positive news, at last, after months of questions about everything including safety and supply shortfalls.

New yorkUnited statesUnited kingdomWhite houseDistrict of columbiaSouth africaTrentino alto adigeBruxelles capitaleNew south walesAngela merkelDonald trumpSarah gilbertFrancis collinsAnthony fauciThierry bretonOxford biomedica